Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Product revenue, net49.64M98.03%
Drug product revenue, net729K1.44%
Development and other revenue269K0.53%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
China109.38M74.03%
Japan15.87M10.74%
United States12.96M8.77%
Europe9.55M6.46%
